T2 Biosystems Inc (TTOO) - Product Pipeline Analysis, 2018 Update

T2 Biosystems Inc (TTOO) - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME16364PD
  • |
  • Pages: 40
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company's T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. T2 Biosystems also offers pipeline products for sepsis management, including bacterial resistance panels, and testing for the superbug Candida auris and a Lyme disease panel. The company's products provide species-specific identification directly from whole blood. It offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians' offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company T2 Biosystems Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

T2 Biosystems Inc Company Overview 5

T2 Biosystems Inc Company Snapshot 5

T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview 5

T2 Biosystems Inc - Pipeline Analysis Overview 8

T2 Biosystems Inc - Key Facts 8

T2 Biosystems Inc - Major Products and Services 9

T2 Biosystems Inc Pipeline Products by Development Stage 10

T2 Biosystems Inc Ongoing Clinical Trials by Trial Status 12

T2 Biosystems Inc Pipeline Products Overview 14

Gram-Negative Resistance Panel 14

Gram-Negative Resistance Panel Product Overview 14

T2Dx - Antimicrobial Resistance 15

T2Dx - Antimicrobial Resistance Product Overview 15

T2Dx - Cancer 16

T2Dx - Cancer Product Overview 16

T2Dx - Cardiac 17

T2Dx - Cardiac Product Overview 17

T2Endotoxin 18

T2Endotoxin Product Overview 18

T2HemoStat 19

T2HemoStat Product Overview 19

T2Lyme Panel 20

T2Lyme Panel Product Overview 20

T2Lyme Panel Clinical Trial 21

T2MR Assay - Platelet Function Testing 22

T2MR Assay - Platelet Function Testing Product Overview 22

T2Plex 23

T2Plex Product Overview 23

T2 Biosystems Inc - Key Competitors 24

T2 Biosystems Inc - Key Employees 25

T2 Biosystems Inc - Key Employee Biographies 26

T2 Biosystems Inc - Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

T2 Biosystems Inc, Recent Developments 28

Jun 13, 2018: Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel Underscore Sepsis Prevention Opportunities at ASM Microbe 2018 28

May 29, 2018: T2 Biosystems Receives FDA Clearance to Market T2Bacteria Panel for Detection of Sepsis-Causing Pathogens 29

May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results 29

Mar 28, 2018: Multiple New Studies Demonstrate T2 Biosystems' Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics 30

Mar 06, 2018: T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update 31

Feb 09, 2018: Two New Studies Demonstrate T2Candida's Advantages over Current Diagnostic Testing 32

Feb 05, 2018: T2 Biosystems Names John Sprague As CFO 33

Jan 04, 2018: T2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and Provides Update on T2Bacteria Panel 34

Nov 20, 2017: T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017 34

Nov 09, 2017: T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017 35

Appendix 37

Methodology 37

About GlobalData 40

Contact Us 40

Disclaimer 40

List of Figures

T2 Biosystems Inc Pipeline Products by Equipment Type 6

T2 Biosystems Inc Pipeline Products by Development Stage 10

T2 Biosystems Inc Ongoing Clinical Trials by Trial Status 12

List of Tables

T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview 5

T2 Biosystems Inc Pipeline Products by Equipment Type 6

T2 Biosystems Inc Pipeline Products by Indication 7

T2 Biosystems Inc Ongoing Clinical Trials by Trial Status 7

T2 Biosystems Inc, Key Facts 8

T2 Biosystems Inc, Major Products and Services 9

T2 Biosystems Inc Number of Pipeline Products by Development Stage 10

T2 Biosystems Inc Pipeline Products Summary by Development Stage 11

T2 Biosystems Inc Ongoing Clinical Trials by Trial Status 12

T2 Biosystems Inc Ongoing Clinical Trials Summary 13

Gram-Negative Resistance Panel - Product Status 14

Gram-Negative Resistance Panel - Product Description 14

T2Dx - Antimicrobial Resistance - Product Status 15

T2Dx - Antimicrobial Resistance - Product Description 15

T2Dx - Cancer - Product Status 16

T2Dx - Cancer - Product Description 16

T2Dx - Cardiac - Product Status 17

T2Dx - Cardiac - Product Description 17

T2Endotoxin - Product Status 18

T2Endotoxin - Product Description 18

T2HemoStat - Product Status 19

T2HemoStat - Product Description 19

T2Lyme Panel - Product Status 20

T2Lyme Panel - Product Description 20

T2Lyme Panel - Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel 21

T2MR Assay - Platelet Function Testing - Product Status 22

T2MR Assay - Platelet Function Testing - Product Description 22

T2Plex - Product Status 23

T2Plex - Product Description 23

T2 Biosystems Inc, Key Employees 25

T2 Biosystems Inc, Key Employee Biographies 26

T2 Biosystems Inc, Other Locations 27

Glossary 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

OpGen Inc

GenMark Diagnostics Inc

Celula Inc

BioFire Diagnostics LLC

Diadexus Inc

Becton Dickinson and Co

T2 Biosystems Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 54390
Site License
USD 1500 INR 108780
Corporate User License
USD 2250 INR 163170

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com